A critical analysis of the COMPASS trial with respect to benefit-risk assessment using the numbers needed to treat: Applicability and relevance in Indian patients with stable cardiovascular disease

The recently published Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial evaluated the hypothesis that rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary prevention. In India, stable cardiovascular disease occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerkar, P., Bose, D., Nishandar, T., Sabnis, G., Kumar, D., Thatte, U.M., Gogtay, N.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306361/
https://www.ncbi.nlm.nih.gov/pubmed/30580865
http://dx.doi.org/10.1016/j.ihj.2018.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306361/
https://www.ncbi.nlm.nih.gov/pubmed/30580865
http://dx.doi.org/10.1016/j.ihj.2018.06.006

Ejemplares similares